EP 4337175 A1 20240320 - PHARMACEUTICAL FORMULATION OF VALSARTAN AND SACUBITRIL
Title (en)
PHARMACEUTICAL FORMULATION OF VALSARTAN AND SACUBITRIL
Title (de)
PHARMAZEUTISCHE FORMULIERUNG VON VALSARTAN UND SAKUBITRIL
Title (fr)
FORMULATION PHARMACEUTIQUE DE VALSARTAN ET DE SACUBITRIL
Publication
Application
Priority
- EP 21173895 A 20210514
- EP 2022063043 W 20220513
Abstract (en)
[origin: EP4088715A1] The invention relates to a pharmaceutical formulation comprising a mixture of a first granular composition comprising valsartan disodium salt and a second composition comprising or essentially consisting of sacubitril sodium salt. The second composition may be non-granular or granular. The invention further relates to a pharmaceutical dosage form comprising such pharmaceutical formulation and to a process for preparing such pharmaceutical formulation.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/216 (2006.01); A61K 31/41 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 31/216 (2013.01); A61K 31/41 (2013.01)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
EP 4088715 A1 20221116; EP 4337175 A1 20240320; WO 2022238563 A1 20221117
DOCDB simple family (application)
EP 21173895 A 20210514; EP 2022063043 W 20220513; EP 22728900 A 20220513